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Conventional antihistamines such as mepyramine maleate do not block the stimulation of gastric secretion by histamine. The concept has arisen that there are two types of histamine receptor in the body, the Hi-receptors sensitive to mepyramine-and the H.-receptors such as those responsible for the mediation of gastric secretion. A group of compounds have recently been developed which are specific H.-receptor antagonistss. The most potent of these compounds, metiamide, inhibits histamine and pentagastrin-induced gastric secretion in manbut its effect on vagally-induced secretion is unknown. The present studies were undertaken to assess the effect of metiamide on vagally-indueed acid secretion in a group of healthy volunteers and patients with duodenal ulceration.
Vagal stimulation was achieved by constant insulin infusion>, In 6 healthy volunteers, 0.03 units insulin per Kg. pel hour were infused for 150 minutes. After 60 minutes of insulin, a second intravenous infusion of 200 mg. per hour of metiamide was commenced and the 2 infusions run concurrently for 75 minutes. In all 6 subjects, paired control tests were performed by omitting metiamide from the saline vehicle in the second infusion. Volume and acid concentration were both reduced by simultaneous metiamide infusion and in all cases the plateau acid output (i.e. sum of the 4 highest consecutive 15 minute acid outputs during the 150 minutes of insulin infusion) was lower in the test using metiamide. Taking all 6 subjects into consideration, the mean plateau acid output in the metiamide tests was 6.22± SD 3.73 m.mols per hour, significantly lower than the mean plateau acid output of 20.9±SD 6.37 m. mols per hour in the paired control studies (t test, p<O.OOI).
In 4 patients with peptic ulceration, single extended tests were performed with infusion of 0.04 units insulin per Kg. per hour for 180 minutes. In these tests, metiamide infusion was delayed until the plateau secretory response to insulin was established and then 200 mg. per hour of metiamide was infused for the last 75 minutes of the 3 hour test. In all cases, metiamide resulted in a marked reduction in acid secretion (Fig. 1) , the mean peak acid output in the last hour of the 4 tests being reduced by 76.9 per cent when compared to the mean peak acid output in the period prios to metiamide infusion. Again the reduction in secretion was achieved by a fall in both the volume and acid concentration of the gastric juice.
It is concluded that metiamide is a potent inhibitor of vagally-induced gastric secretion in man. If this inhibitory effect extends to pepsin secretion and if current toxicity trials are satisfactorily completed, a therapeutic trial of this agent in the peptic ulcer diathesis is indicated. Regardless of its therapeutic potential, metiamide and the H.-receptor blockers should prove valuable research tools. While at first sight, the success of metiamide as an inhibitor of gastric secretion SUPPOItS the concept that histamine is the 'final common pathway' an alternative hypothesis suggests interaction may occur between
